ATOM Coalition Seeks Partners To Create New Oncology Markets
Cancer Treatment Coalition Will Work With Partners To Expand Access In LLMICs
Executive Summary
The ATOM Coalition is seeking partners in the generics and biosimilars industry to help create new markets for cancer medicines in LLMICs.
You may also be interested in...
Medicines Patent Pool Unveils Quartet Of Nilotinib Licensees
Details of the four firms that have been selected to manufacture generic versions of Novartis’s nilotinib treatment for chronic myeloid leukemia have been revealed by the Medicines Patent Pool.
MPP Unveils Quartet Of Nilotinib Licensees
Details of the four firms that have been selected to manufacture generic versions of Novartis’s nilotinib treatment for chronic myeloid leukemia have been revealed by the Medicines Patent Pool.
Generics Bulletin Editor’s Picks For Q1 2023
Looking back over the first quarter of 2023, Generics Bulletin executive editor Dave Wallace picks out highlights from January to March that include the launch of the first US Humira biosimilar, new leadership at the top of some of the industry’s biggest players, annual results and strategy updates, and multiple major industry conferences – as well as the launch of our annual awards.